Thus, we speculate that this newly characterized regulatory pathway makes an important contribution to the amelioration of hepatic steatosis in subjects with lipodystrophy under leptin treatment, which until now has often been attributed solely to leptin induced anorexia and weight loss8,11. This evidence concerns the gene LEP and Hepatic steatosis.